Children and adults with mild COVID-19 symptoms develop memory T cell immunity to SARS-CoV-2
Preprint
Abstract
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to considerable morbidity/mortality worldwide, but most infections, especially among children, have a mild course. However, it remains largely unknown whether infected children develop cellular immune memory. Methods: To determine whether a memory T cell response is being developed as an indicator for long-term immune protection, we performed a longitudinal assessment of the SARS-CoV-2-specific T cell response by IFN-γ ELISPOT and activation marker expression analyses of peripheral blood samples from children and adults with mild-to-moderate COVID-19. Results: Upon stimulation of PBMCs with heat-inactivated SARS-CoV-2 or overlapping peptides of spike (S-SARS-CoV-2) and nucleocapsid proteins, we found S-SARS-CoV-2-specific IFN-γ T cell responses in most infected children (83%) and all adults (100%) that were absent in unexposed controls. Frequencies of SARS-CoV-2-specific T cells were higher in infected adults, especially in those with moderate symptoms, compared to infected children. The S-SARS-CoV-2 IFN-γ T cell response correlated with S1-SARS-CoV-2-specific serum IgM, IgG, and IgA antibody concentrations. Predominantly, effector memory CD4 + T cells of a Th1 phenotype were activated upon exposure to SARS-CoV-2 antigens, which persisted for 4-8 weeks after symptom onset. We detected very low frequencies of SARS-CoV-2-reactive CD8 + T cells in these individuals. Conclusions: Our data indicate that an antigen-specific memory CD4 + T cell response is induced in children and adults with mild SARS-CoV-2 infection. T cell immunity induced after mild COVID-19 could contribute to protection against re-infection.Keywords
All Related Versions
- Published version: Frontiers in Immunology, 13, 817876.
This publication has 28 references indexed in Scilit:
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsScience, 2020
- Longitudinal analyses reveal immunological misfiring in severe COVID-19Nature, 2020
- Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19Virologica Sinica, 2020
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNature, 2020
- SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protectionScience Immunology, 2020
- Comprehensive mapping of immune perturbations associated with severe COVID-19Science Immunology, 2020
- Immune response in children with COVID‐19 is characterized by lower levels of T‐cell activation than infected adultsEuropean Journal of Immunology, 2020
- Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndromeScience Immunology, 2020
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory FailureCell Host & Microbe, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020